Custom Search Insider Trading Activity Insider Trading Activity
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Custom Search Insider Trading Activity
Updated Jun 4, 2024
Ticker
|
Company Name
|
Qty.
|
Price
|
Size ($)
|
Filing Date
|
Type
|
Δ Own
|
Own
|
Insider Names
|
Title
|
Trade Dates
|
Is Scheduled
| |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Exelixis, Inc.
| 18.84K |
—
|
—
| +1.49% | 1.28M |
May 31
| |||||||
Exelixis, Inc.
| 249 |
$20.29 | -$11,481.98 | +0.02% | 1.26M |
May 20
| |||||||
Regulus Therapeutics Inc.
|
0
|
—
|
—
|
—
|
0
|
May 20
| |||||||
Regulus Therapeutics Inc.
|
0
|
—
|
—
|
—
|
0
|
May 16
| |||||||
Regulus Therapeutics Inc.
| 250K |
$1.60 | $400,000.00 | +34.32% | 978.39K |
Mar 14
| |||||||
Regulus Therapeutics Inc.
|
0
|
—
|
—
|
—
|
0
|
Aug 10
| |||||||
Regulus Therapeutics Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 13
| |||||||
Exelixis, Inc.
| 20.72K |
—
|
—
| +1.67% | 1.26M |
Jun 1
| |||||||
Regulus Therapeutics Inc.
| 222.2K |
$0.90 | $200,000.42 | +43.90% | 728.39K |
Apr 13
| |||||||
Biogen Inc.
| 2.25K |
—
|
—
| +28.76% | 10.1K |
Jun 15
| |||||||
Regulus Therapeutics Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 9
| |||||||
Exelixis, Inc.
| 19.57K |
—
|
—
| +1.60% | 1.24M |
May 26
| |||||||
Exelixis, Inc.
| -84.52K |
$19.56 | -$1,653,113.40 | -6.48% | 1.22M |
Feb 22
| |||||||
Regulus Therapeutics Inc.
| 2.22M |
$0.36 | $799,999.92 | +78.26% | 5.06M |
Nov 30
| |||||||
Biogen Inc.
| 1.27K |
—
|
—
| +19.42% | 7.84K |
Jul 1
| |||||||
Regulus Therapeutics Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 14
| |||||||
Exelixis, Inc.
| 16.42K |
—
|
—
| +1.28% | 1.3M |
May 27
| |||||||
Exelixis, Inc.
| 99.23K |
$14.63 | -$6,393.63 | +8.35% | 1.29M |
May 11
| |||||||
Regulus Therapeutics Inc.
| 793.53K |
$0.63 | $500,001.99 | +38.78% | 2.84M |
Dec 4
| |||||||
Regulus Therapeutics Inc.
| 793.53K |
$0.63 | $500,001.99 | +66.50% | 1.99M |
Dec 4
| |||||||
Eucrates Biomedical Acquisition Corp.
| -255.09K |
—
|
—
| -8.87% | 2.62M |
Nov 24
| |||||||
Eucrates Biomedical Acquisition Corp.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Regulus Therapeutics Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 17
| |||||||
Biogen Inc.
| 1.47K |
—
|
—
| +28.85% | 6.57K |
Jun 3
| |||||||
Exelixis, Inc.
| 15.54K |
—
|
—
| +1.32% | 1.19M |
May 21
| |||||||
Exelixis, Inc.
| 120.79K |
$5.82 | $703,003.62 | +11.48% | 1.17M |
May 13
| |||||||
Exelixis, Inc.
|
0
|
$15.44 | -$936,600.00 |
—
| 1.05M |
May 8
| |||||||
Regulus Therapeutics Inc.
| 846.32K |
—
|
—
| +70.93% | 2.04M |
Feb 3
| |||||||
Regulus Therapeutics Inc.
|
0
|
—
|
—
|
—
|
0
|
Dec 24
| |||||||
Regulus Therapeutics Inc.
|
0
|
—
|
—
|
—
|
0
|
Oct 10
| |||||||
Biogen Inc.
| 1.91K |
—
|
—
| +59.72% | 5.09K |
Jun 19
| |||||||
Exelixis, Inc.
| 10.32K |
—
|
—
| +0.99% | 1.05M |
May 23
| |||||||
Regulus Therapeutics Inc.
| 370.37K |
$1.08 | $399,999.60 | +45.19% | 1.19M |
May 7
| |||||||
Regulus Therapeutics Inc.
| 370.37K |
$1.08 | $399,999.60 | +45.19% | 1.19M |
May 7
| |||||||
Exelixis, Inc.
|
0
|
$12.82 | -$442,462.50 |
—
| 1.04M |
Feb 21
| |||||||
Regulus Therapeutics Inc.
| 50K |
$1.09 | $54,570.00 | +6.37% | 835.07K |
Dec 28
| |||||||
Regulus Therapeutics Inc.
| 116.4K |
$0.97 | $113,337.68 | +17.41% | 785.07K |
Dec 26 - Dec 27
| |||||||
Regulus Therapeutics Inc.
| 20.91K |
—
|
—
| +14.15% | 168.67K |
Nov 12
| |||||||
Regulus Therapeutics Inc.
| 500K |
$1.36 | $680,550.00 | +296.43% | 668.67K |
Nov 15 - Nov 16
| |||||||
Biogen Inc.
| 1.45K |
—
|
—
| +83.33% | 3.19K |
Jun 12
| |||||||
It looks like there's no data for these filter options. Maybe you'll be interested in these options instead. | |||||||||||||
Want to view more results?
Unlock the hidden results with your Benzinga Account now. No purchase required.